Table 2 Antenatal care services received and prevalence of screened conditions among 1491 women
Characteristic | Services received at clinics | Prevalence | 95% CI |
|---|---|---|---|
n (%) | n (%) | ||
HIV Status | |||
 -Total Screened | 1237 (82.96) |  |  |
 -Tested Positive |  | 48 (3.88) | 2.80–4.95 |
 -Tested Negative |  | 1189 (96.12) |  |
Hemoglobin level | |||
 -Total screened | 721 (48.36) |  |  |
 -Hb level < 10.9 g/dL |  | 390 (54.09) | 50.45–57.74 |
 -Hb level > =10.9 g/dL |  | 331 (45.91) |  |
Syphilis status | |||
 -Total Screened | 97 (6.51) |  |  |
  - Tested Positive |  | 18 (18.57) | 10.68–26.43 |
 - Tested Negative |  | 79 (81.43) |  |
Iron supplements | 1135 (76.12) | Â | Â |
Antihelminthic drugs | |||
 - None | 520 (34.87) |  |  |
 - One Dose | 475 (31.86) |  |  |
 - Two Doses | 496 (33.27) |  |  |
Intermittent preventive treatment | |||
 - None | 353 (23.68) |  |  |
 - One Dose | 518 (34.74) |  |  |
 -Two Doses | 620 (41.58) |  |  |
Tetanus toxoid vaccine | |||
 - None | 134 (8.99) |  |  |
 - One Dose | 229 (15.36) |  |  |
 -Two or more doses | 1128 (75.65) |  |  |